Cell polarity regulators in tumor formation and progression

Research focus

Cell polarization is crucial for the development of multicellular organisms, and aberrant cell polarization contributes to various diseases. Seminal studies in invertebrates identified proteins that regulate various polarization processes including asymmetric cell division and epithelial cell polarization. Mammalian homologs have been shown to direct for instance neuronal polarization, polarized cell migration and immunological synapse formation. Polarity proteins may react to extrinsic polarity cues such as growth factor gradients or intrinsic polarity cues such as the microtubule cytoskeleton. By assembling multiprotein complexes, they induce downstream signaling to trigger the establishment of cellular asymmetry. Of the three described polarity protein complexes — partitioning defective-3 (Par3), Crumbs and Scribble — the Par3 complex has the broadest function. Furthermore, cross-talk between polarity proteins and Rho GTPase signaling components controls the establishment of cell-cell contacts and apico-basal polarity of epithelial cells. For decades, loss of apico-basal polarity has been considered a prerequisite for tumor formation and progression. However, the contribution of mammalian polarity proteins to these processes is currently unclear.

Research in our junior group addresses the function of polarity proteins in skin pathologies including cancer. In experimental skin tumor models, we have observed that mice with deregulated polarity signalling exhibit altered skin tumorigenesis. We investigate cell-autonomous and non-cell-autonomous functions of polarity proteins and study consequences of loss of polarity proteins on cellular architecture, survival mechanisms and cell death using cell culture techniques and different mouse models. Overall, we aim at a better understanding of polarity regulators in health and disease, which may reveal future directions for targeted therapies.

Principal Investigators

Sandra Iden

Dr. rer. nat. Sandra Iden

University Hospital of Cologne
CECAD/SFB829/SFB832
located in the ZMMK Building
Robert-Koch-Strasse 21
50931 Cologne
Phone: +49 221 478-89587
Fax: +49 221 478-86737
Email:

Scientific career

1998-2003
University of Hannover, Germany (Biochemistry)
2003-2007
PhD student at the Institutes of Cell Biology and Medical Biochemistry, University Hospital Münster, Germany
2007
Dr. rer. nat., University of Münster, Germany
2007-2010
Research associate at the Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
since 2011
Junior Group Leader at CECAD / SFB829 / SFB832, Cologne, Germany

News

09 May 2012
CRC832 Seminar Series

Transcriptional networks regulating EMT and tumor progression (G. Christofori)
more »

14 - 16 May 2012
International Symposium of the Collaborative Research Center 832
Bad Neuenahr, Germany
more »

27 Feb 2012
Gunther Hartmann receives the Leibniz Prize 2012 together with Christian Kurts
press release »

Gender & Family Support
Flyer: women in science | work-life-balance »

Publications
aPKC phosphorylates JAM-A at Ser285 to promote cell contact maturation and tight junction formation (Iden S et al.)
more »